Informējam, ka Sistēma pielāgota darbam ar interneta pārlūkprogrammu Internet Explorer (8. un jaunākām versijām) un Mozilla Firefox (3.6 un jaunākām versijām).
Izmantojot citu interneta pārlūkprogrammu, brīdinām, ka Sistēmas funkcionalitāte var tikt traucēta.
This document specifies the requirements and methods for characterization and evaluation of recombinant collagen as starting material for implants, including requirements for quality assessment and quality control, test items and corresponding methods, packaging and storage.
This document is intended to be used for the quality assessment and quality control of recombinant collagen.
This document is not applied for recombinant collagen which will be used as medicine for the treatment of collagen related genetic diseases, such like recombinant collagen VII for the treatment of Epidermolysis bullosa.
Reģistrācijas numurs (WIID)
94085
Darbības sfēra
This document specifies the requirements and methods for characterization and evaluation of recombinant collagen as starting material for implants, including requirements for quality assessment and quality control, test items and corresponding methods, packaging and storage.
This document is intended to be used for the quality assessment and quality control of recombinant collagen.
This document is not applied for recombinant collagen which will be used as medicine for the treatment of collagen related genetic diseases, such like recombinant collagen VII for the treatment of Epidermolysis bullosa.
